USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S. Biotechnology Industry Overview & Growth Strategy Framework
U.S. Biotechnology Industry Overview & Growth Strategy Framework
RELEASE DATE
03-Sep-2002
03-Sep-2002
REGION
North America
North America
Research Code: A291-01-00-00-00
SKU: HC00846-NA-MR_04559
$2,450.00
Special Price $1,837.50 save 25 %
In stock
SKU
HC00846-NA-MR_04559
Description
This study describes and analyzes the biotechnology industry, focusing on biotechnology therapeutics. The study includes a discussion of drivers, restrains, technologies, research and development, manufacturing, regulatory issues, products, partnerships and capital markets. This study also presents a startegy framework that identifies key competencies for the growth of biotech companies.
Table of Contents
Executive Summary & Introduction
- Executive Summary
- Introduction
- Focus of this Report
Drivers
- Market Drivers
- Non-Market Drivers
Restraints
- Market Restraints
- Non-Market Restraints
Drug Development Technologies
Research & Development Process
Manufacturing Process
- Technology Overview
- Protein Therapeutics
- Monoclonal Antibodies
- Gene Therapy
- Antisense Technology
- Brief Description of Enzyme Inhibitors Fusion Inhibitors and Other Technologies
Overview of the FDA
FDA Process
Products
Partnerships
Capital Markets
Overview
Competencies and Growth
Awards
This study describes and analyzes the biotechnology industry, focusing on biotechnology therapeutics. The study includes a discussion of drivers, restrains, technologies, research and development, manufacturing, regulatory issues, products, partnerships and capital markets. This study also presents a startegy framework that identifies key competencies for the growth of biotech companies.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | A291-01-00-00-00 |
| Is Prebook | No |